New CAR T-Cell Therapy Tested for Lupus

A new CAR T-cell therapy trial for lupus has begun in the UK, with three patients receiving treatment aimed at potentially eliminating the need for lifelong medication. This groundbreaking approach, traditionally used for cancer, involves genetically modifying cells to help the immune system attack lupus-affected cells, offering hope for a possible cure. Early indications from previous treatments in Germany show patients achieving remission. One participant, 50-year-old Katie Tinkler, expressed her excitement, stating that if successful, it would be life-changing. Lupus affects approximately 69,000 people in the UK and is characterized by an overactive immune response that can cause severe damage to organs. Experts believe that this innovative therapy could revolutionize lupus treatment and significantly improve patients' quality of life.